InsidersTradesSigma
Ajanta Pharma Limited: insider trades · India · SEBI (PIT + SAST)
SEBI:ajanta-pharma-limitedIN·SEBI (PIT + SAST)Mcap 350.3Bn€
Discover the full directors' dealings record of Ajanta Pharma Limited, a publicly traded company based in India. Shares trade on IN IN, under the oversight of SEBI (PIT + SAST). Market capitalisation: €350.3bn. The latest transaction was reported on 13 March 2026 — Sale. Among the most active insiders: Ravi P Agrawal, trustee Ravi Agrawal Trust. Every trade is accessible without an account.
229
Insider Decl.
0
Thresholds
€25,087
24 ops.
Buy Volume
€90m
82 ops.
Sell Volume
Financial data
FY ended March 2026 · cache
3214.10 €
Income statement
Revenue54.53 Bn€
Gross profit42.69 Bn€78% margin
Net income10.56 Bn€19.4% margin
Balance sheet & cash
Market cap350.26 Bn€
Total debt2.60 Bn€
Free Cash Flow1.64 Bn€
Last declaration on 13 March 2026
Declarations0 total
No declarations found
0 of 0 declarations
About Ajanta Pharma Limited
Ajanta Pharma Limited is an Indian pharmaceutical company specializing in the manufacture of generic drugs and healthcare products. It is listed on the Bombay Stock Exchange.